ID   HS_PRDX5     standard; region; VRT.
XX
AC   EP74280;
XX
DT   10-JAN-2003 (Rel. 73, created)
DT   13-SEP-2004 (Rel. 80, Last annotation update).
XX
DE   Peroxiredoxin 5.
OS   Homo sapiens (human).
XX
HG   none.
AP   none.
NP   none.
XX
DR   GENOME; NT_033903.7; NT_033903; [-9391450, 5004146].
DR   CLEANEX; HS_PRDX5.
DR   EMBL; AP001453.6; [-90365, 75991].
DR   EMBL; DQ247769.1; [-2040, 5597].
DR   SWISS-PROT; P30044; PRDX5_HUMAN.
DR   RefSeq; NM_012094.
DR   MIM; 606583.
XX
RN   [1]
RX   MEDLINE; 10521335.
RA   Strausberg RL., Feingold EA., Klausner RD., Collins FS.;
RT   The mammalian gene collection;
RL   Science 286:455-457(1999).
XX
ME   Mammalian gene collection (MGC) full-length cDNA cloning [1].
XX
SE   cgccgctgtgccgctagcggtgccccgcctgctgcggtggcaccagccaGGAGGCGGAGT
XX
FL             DBTSS     MGC
IF   -134 G              1
IF   -67  C              1
IF   -65  G              1
IF   -55  G              1
IF   -51  G              1
IF   -49  C              1
IF   -47  C              3
IF   -38  C              1
IF   -36  C              1
IF   -34  A              2
IF   -26  C              1
IF   -23  G              1
IF   -22  C              2
IF   -18  C              1
IF   -15  C              1
IF   -13  G              1
IF   -9   C              1
IF   -7   C              1
IF   -2   C              1
IF    0   G              5
IF   +3   G              2
IF   +6   G              1
IF   +8   A              1
IF   +9   G              1
IF   +11  G              1
IF   +15  G              2
IF   +17  G              1
IF   +18  G              1
IF   +21  G              1
IF   +22  T              2
IF   +25  G              1
XX
TX   6. Vertebrate promoters
TX   6.1. Chromosomal genes
TX   6.1.7. Unclassified
XX
KW   Antioxidant, Peroxisome, Mitochondrion, Transit peptide,
KW   Alternative initiation, Polymorphism, 3D-structure.
XX
FP   Hs PRDX5            :+R  EU:NC_000011.8       1+  63842232; 74280.
XX
DO        Experimental evidence: 12
DO        Expression/Regulation:
RF        Sci286:455
//